CIPRO HC OTIC Rx
Generic Name and Formulations:
Ciprofloxacin (as HCl) 0.2%, hydrocortisone 1%; otic susp.
Alcon Laboratories, Inc.
Indications for CIPRO HC OTIC:
Acute otitis externa.
Adults and Children:
To minimize dizziness, warm susp by holding bottle in hand for 1–2 minutes before use. <1yr: not recommended. ≥1yr: 3 drops in affected ear(s) twice daily for 7 days.
Perforated tympanic membrane. Viral otic infections (eg, varicella, herpes simplex).
Discontinue at 1st sign of a skin rash or any other hypersensitivity reactions occur. Reevaluate if no improvement after 1 week. Latex allergy. Pregnancy. Nursing mothers: not recommended.
Antibiotic (quinolone) + steroid.
Susp—10mL (w. dropper)
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- The Caregivers' Cancer Journey
- Staff Education Leads to Increase in Oncology Rehabilitation Referrals
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Gender Bias in Medicine Has Far-Reaching Consequences
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Patient Interest in Melanoma Genetic Risk Testing is Fairly High
- Genetic Link Between Depression and Breast Cancer Remains Unclear
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|